In a prospective study , consecutive patients with decompensated cirrhosis seen at the Institute of Liver and Biliary Sciences , New Delhi ( from May @ through June @ ) were randomly assigned to groups given subcutaneous G-CSF ( @ g/kg/d ) for @ days and then every third day ( @ total doses ) , along with subcutaneous darbopoietin ( @ mcg/wk ) for @ weeks ( GDP group , n = @ ) , or only placebos ( control group , n = @ ) .